SMTL ID : 9fqp.1

EGFR Exon20 insertion mutant NPG bound with Compound 23

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 01: (7~{S})-3-[(3-chloranyl-2-methoxy-phenyl)amino]-2-(3-fluoranylpyridin-4-yl)-7-(2-methoxyethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one

01.1: 23 residues within 4Å: Chain A: L.25, G.26, F.30, V.33, A.50, I.51, K.52, E.69, M.73, L.87, L.98, I.99, T.100, Q.101, L.102, M.103, C.107, R.151, N.152, L.154, T.164, D.165, F.166 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.33, A:V.33, A:K.52, A:L.98, A:T.100, A:L.154 Hydrogen bonds: A:K.52, A:M.103, A:T.164, A:T.164, A:D.165, A:D.165, A:D.165

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Milgram, B.C. et al., Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung Cancer. J.Med.Chem. (2025)

Release Date

2025-01-29

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence